The effects of denosumab on calcium profiles in advanced cancer patients with bone metastases

被引：0
|
作者：
Breanne Lechner
Carlo DeAngelis
Noreen Jamal
Urban Emmenegger
Natalie Pulenzas
Angie Giotis
Parker Sheehan
May Tsao
Gillian Bedard
Edward Chow
机构：
[1] University of Toronto,Rapid Response Radiotherapy Program, Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[2] University of Toronto,Department of Pharmacy, Odette Cancer Centre, Sunnybrook Health Sciences Centre
[3] University of Toronto,Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre
来源：
Supportive Care in Cancer | 2014年 / 22卷
关键词：
Denosumab; Hypocalcemia; Bone metastases;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1765 / 1771
页数：6
相关论文
共 50 条
  • [41] Effects of denosumab as compared with parathyroidectomy regarding calcium, renal, and bone involvement in osteoporotic patients with primary hyperparathyroidism
    Miyaoka, Daichi
    Imanishi, Yasuo
    Kato, Eiko
    Toi, Norikazu
    Nagata, Yuki
    Kurajoh, Masafumi
    Yamada, Shinsuke
    Inaba, Masaaki
    Emoto, Masanori
    ENDOCRINE, 2020, 69 (03) : 642 - 649
  • [42] Pharmacotherapy of bone metastases in breast cancer patients - an update
    Jacobs, Carmel
    Simos, Demetrios
    Addison, Christina
    Ibrahim, Mohammed
    Clemons, Mark
    EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (08) : 1109 - 1118
  • [43] CECOG experts' recommendations on the use of denosumab in the prevention of skeletal-related events in bone metastases of lung cancer
    Hilbe W.
    Abacioglu U.
    Aebersold D.M.
    Bachouchi M.
    Brodowicz T.
    Gaafar R.
    Holzer G.
    Mohn-Staudner A.
    Kalev D.
    Kalinka-Warzocha E.
    Kovac V.
    Siano M.
    Yumuk F.
    Tamasi L.
    memo - Magazine of European Medical Oncology, 2013, 6 (2) : 75 - 82
  • [44] Use of denosumab in a dialysis patient with bone metastases from breast cancer and hepatorenal polycystic disease: a case report
    Quiroga Garcia, Vanesa
    Cirauqui Cirauqui, Beatriz
    Tobey Robaina, Lyan
    Lopez Sisamon, David
    Hardy-Werbin, Max
    Belen Blanca, Ana
    Margeli Vila, Mireia
    ANTI-CANCER DRUGS, 2016, 27 (05) : 464 - 469
  • [45] Efficacy of zoledronic acid in the prevention of bone metastases in patients with locally advanced prostate cancer
    Musaev, T. N.
    Zeinalov, B. S.
    Kerimov, A. Kh.
    Guliev, F. A.
    Musaev, I. N.
    Alizade, A. M.
    Adzhalov, O. V.
    ONKOUROLOGIYA, 2011, 7 (01): : 62 - 65
  • [46] Bone metastases and immunotherapy in patients with advanced non-small-cell lung cancer
    Landi, Lorenza
    D'Inca, Federica
    Gelibter, Alain
    Chiari, Rita
    Grossi, Francesco
    Delmonte, Angelo
    Passaro, Antonio
    Signorelli, Diego
    Gelsomino, Francesco
    Galetta, Domenico
    Giannarelli, Diana
    Parra, Hector Soto
    Minuti, Gabriele
    Tiseo, Marcello
    Migliorino, Maria Rita
    Cognetti, Francesco
    Toschi, Luca
    Bidoli, Paolo
    Piantedosi, Francovito
    Calabro, Luana
    Cappuzzo, Federico
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7 (01):
  • [47] Safety of Denosumab Versus Zoledronic Acid in Patients with Bone Metastases: A Meta-Analysis of Randomized Controlled Trials
    Chen, Fengxia
    Pu, Feifei
    ONCOLOGY RESEARCH AND TREATMENT, 2016, 39 (7-8) : 453 - 459
  • [48] Efficacy and Safety of Denosumab Versus Zoledronic Acid in Patients With Bone Metastases A Systematic Review and Meta-analysis
    Sun, Lei
    Yu, Shiying
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2013, 36 (04): : 399 - 403
  • [49] Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases
    Simos, Demetrios
    Addison, Christina L.
    Kuchuk, Iryna
    Hutton, Brian
    Mazzarello, Sasha
    Clemons, Mark
    JOURNAL OF CLINICAL MEDICINE, 2013, 2 (03) : 67 - 88
  • [50] Denosumab in patients with cancer and skeletal metastases: A systematic review and meta-analysis
    Peddi, Prashanth
    Lopez-Olivo, Maria A.
    Pratt, Gregory F.
    Suarez-Almazor, Maria E.
    CANCER TREATMENT REVIEWS, 2013, 39 (01) : 97 - 104
12345